Tryp Therapeutics Inc. announced the appointment of Australia-based Jason Carroll as the Company's new Chief Executive Officer, beginning October 1, 2023. Mr. Carroll brings a wealth of experience as a highly regarded life sciences executive, with an impressive 32-year career in the industry. In addition to his most recent role as Managing Director of iNova Pharmaceuticals Philippines, his extensive background includes leadership roles at industry giants Johnson & Johnson, Janssen Pharmaceutica, and Bristol-Myers Squibb.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | 0.00% | +9.09% | +50.00% |
Mar. 08 | Tryp Therapeutics Inc. announced that it has received AUD 3.39 million in funding | CI |
Feb. 05 | Tryp Therapeutics Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.00% | 4.24M | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- TRYP Stock
- News Tryp Therapeutics Inc.
- Tryp Therapeutics Announces Appointment of Jason Carroll as New Chief Executive Officer, Effective October 1, 2023